SAN DIEGO, Sept. 24, 2019 /AxisWire/ Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinzwill be a featured speaker at the MJBizDaily Latin American Cannabis Symposium in Bogotá, Columbia, on Sept. 30Oct. 1.

Caroline Heinz will speak on Oct. 1 at 9:50 a.m. on a panel entitled “Potential Powerhouse: Where Brazil Stands” discussing the potential for upcoming reform in which domestic cultivation would be regulated and cannabis products could be registered without finished clinical trials for the first time in Brazil. The panel will also discuss how to prepare to cultivate cannabis in Brazil and what significant new business opportunities this reform could create for the entire Latin American cannabis industry.

“We’re currently on the precipice of a monumental positive shift in acceptance and support for cannabis in Brazil,” Heinz said. “I’m honored to be speaking at this event and educating people about the potential business prospects with this new reform and how our Company will continue to be a pioneer in enhancing how Brazilian citizens use cannabidiol (CBD) in their everyday lives.”

The MJBizDaily Latin American Cannabis Symposium is a platform for cannabis industry innovators, researchers and policy decision-makers to participate in an intensive two-day event to discuss the latest technology advancements, scientific research and potential for growth in the Latin American and the Caribbean markets.

Founded in 2014, HempMeds® Brasil is the first company to be authorized by the National Sanitary Surveillance Agency (Anvisa) to import CBD-based products. Real Scientific Hemp Oil™ (RSHO™) was the first product approved for import and use in the country and is still the leading CBD brand in the market today.

“According to New Frontier Data, the Total Addressable Market (TAM) size for Latin America in 2019 is $9.8 billion and Brazil makes up the largest portion of that revenue with a TAM of $2.4 million,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re excited to be a part of this evolving legal landscape in Brazil and to have Caroline speaking at such a highly regarded industry event.”

To learn more about HempMeds® Brasil, please visit

About HempMeds® Brasil 
HempMeds® Brasil was the first company to receive approval from the National Sanitary Surveillance Agency (Anvisa) to import a product based on cannabidiol, a substance derived from hemp, a plant of the genus Cannabis. Currently, it is authorized to supply its products, which help in the control of diseases such as epilepsy, Parkinson’s, chronic pain and multiple sclerosis, under medical prescription. For these indications, the products can be subsidized by the Brazilian government. HempMeds® Brasil works on additional approvals for other indications.

About Medical Marijuana, Inc.
We are a company of firsts®.  Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at or by visiting

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

Media Inquiries:

You Just Read:

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Presents at MJBizDaily Latin American Cannabis Symposium